Molecular biologist and @mariecurie_alum interested in Genomics & Epigenomics and the next big thing in single cell sequencing
@vbcf_tweets @viennabiocenter
I really enjoy being a single-cell specialist at the NGS facility at @viennabiocenter. Feels somewhat logical to previously having produced one of the scarce whole-genome datasets coming from @CarolineDeanLab at @JohnInnesCentre
Fresh of the press:
https://t.co/wHLxvggYYl
@CG_ath@NascArabidopsis Maybe find some lab in the UK willing to order for you. They can ship it unlabelled in an inconspicuous package. That's what we used to do all the time shipping seeds to China, or vice versa
Only two weeks left to apply! If you're interested in plant-pathogen coevolution and molecular biology consider applying for this PhD position via https://t.co/aDuU86ADvO
Thank you to the other authors, particularly Govind Menon, for developing the beautiful mathematical model.
And everyone else who contributed to settling the role of COOLAIR during vernalization @zhao_yusheng@emateobonmati@wolffsworld and Shaoli Zhou
New Brief Comm: "Integrated single-nucleus and spatial transcriptomics captures transitional states in soybean nodule maturation" https://t.co/O0r9ccwDhD
The approach identifies a rare cell type that specifically expresses numerous genes required for symbiotic N fixation.
Maybe that's how you boycott a World Cup in Katar when you're forced to play anyway: just play the least amount of matches possible ⚽🇩🇪 #BoycottQatar2022
"Recent rhetoric from the home secretary on immigration, including a proposed crackdown on postgraduate students, and the cost of UK visas – by far the most expensive of all G7 countries – gave a perception that international scientists were unwelcome"
https://t.co/x4ev5Q9PZz
@mikegalsworthy Well, accommodation is the only "property" all people try to sell later on with huge profit margin. What's the problem buying a house for 100k and sell it for 75k 20 years later? I mean, why's there no tear&wear in the housing market?
@mikhailspivakov Would you cite it the other way around as well?
Usually it's Name1 et al.
To highlight your (2nd position) co-first authorship Name1, Name2 et al. is ok in presentations, ect.
For CV I'd be honest and transparent: use bold font for your name plus asterisks when shared first